![George A. Skouras](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van George A. Skouras
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cue Capital LP
![]() Cue Capital LP Investment ManagersFinance Cue Capital LP engages in the provision of strategic fund raising for fund management teams. It offers discovery meetings, due diligence, strategic consulting, and fundraising. The company was founded by George Skouras in 2003 and is headquartered in New York, NY. | Algemeen Directeur | 01-01-2003 | - |
Oprichter | 01-01-2003 | - | |
Olatec Therapeutics LLC
![]() Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Directeur/Bestuurslid | - | - |
Loopbaan van George A. Skouras
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Chief Executive Officer | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sectoraal
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Cue Capital LP
![]() Cue Capital LP Investment ManagersFinance Cue Capital LP engages in the provision of strategic fund raising for fund management teams. It offers discovery meetings, due diligence, strategic consulting, and fundraising. The company was founded by George Skouras in 2003 and is headquartered in New York, NY. | Finance |
Olatec Therapeutics LLC
![]() Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- George A. Skouras
- Ervaring